Optimizing Modified mRNA In Vitro Synthesis Protocol for Heart Gene Therapy

Area of Science:

• Molecular Biology
• Biotechnology
• Gene Therapy

Background:

• Synthetic modified RNA (modRNA) is an emerging vector for transient gene transfer with low immunogenicity and no risk of genome integration.
• modRNA is increasingly utilized in clinical trials and scientific research for its therapeutic potential.
• Current modRNA preparation methods are complex and expensive, limiting broader application.

Purpose of the Study:

• To develop a more cost-efficient and accessible protocol for modRNA preparation.
• To optimize modRNA yield, translation efficiency, and reduce immunogenicity through reagent ratio adjustments.

Main Methods:

• Investigated the impact of varying the ratio between anti-reverse cap analog (ARCA) and N1-methyl-pseudouridine (N1mΨ) during modRNA synthesis.
• Assessed modRNA yield, protein expression (translation), and innate immune response (immunogenicity) in vitro.

Main Results:

• Favoring ARCA over N1mΨ in the reagent ratio significantly increased modRNA yield per reaction.
• The modified protocol enhanced modRNA translation efficiency.
• Reduced immunogenicity of modRNA was observed in vitro with the optimized ratio.

Conclusions:

• The optimized modRNA preparation protocol offers a cost-efficient and accessible method for researchers.
• This improved protocol facilitates wider adoption of modRNA technology in basic and translational science.
• The findings contribute to making modRNA a more practical tool for gene transfer applications.